Cargando…
SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma
Pharmacological inhibition of the sonic hedgehog (SHH) pathway can be beneficial against certain cancers but detrimental in others. Adamantinomatous craniopharyngioma (ACP) is a relevant pituitary tumour, affecting children and adults, that is associated with high morbidity and increased mortality i...
Autores principales: | Carreno, G, Boult, J K R, Apps, J, Gonzalez-Meljem, J M, Haston, S, Guiho, R, Stache, C, Danielson, L S, Koers, A, Smith, L M, Virasami, A, Panousopoulos, L, Buchfelder, M, Jacques, T S, Chesler, L, Robinson, S P, Martinez-Barbera, J P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378366/ https://www.ncbi.nlm.nih.gov/pubmed/30645190 http://dx.doi.org/10.1530/ERC-18-0538 |
Ejemplares similares
-
Preclinical transgenic and patient‐derived xenograft models recapitulate the radiological features of human adamantinomatous craniopharyngioma
por: Boult, Jessica K. R., et al.
Publicado: (2017) -
CTNNB1 mutations are clonal in adamantinomatous craniopharyngioma
por: Apps, J. R., et al.
Publicado: (2020) -
Adamantinomatous craniopharyngioma as a model to understand paracrine and senescence-induced tumourigenesis
por: Gonzalez-Meljem, Jose Mario, et al.
Publicado: (2021) -
Stem cell senescence drives age-attenuated induction of pituitary tumours in mouse models of paediatric craniopharyngioma
por: Gonzalez-Meljem, Jose Mario, et al.
Publicado: (2017) -
Molecular and cellular pathogenesis of adamantinomatous craniopharyngioma
por: Martinez‐Barbera, Juan Pedro
Publicado: (2015)